Steven Cohen’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
53,000
-94,600
-64% -$2.17M ﹤0.01% 2782
2026
Q1
$3.25M Sell
147,600
-208,900
-59% -$3.64M ﹤0.01% 1985
2025
Q4
$4.2M Buy
356,500
+106,500
+43% +$1.37M ﹤0.01% 1965
2025
Q3
$3.96M Buy
+250,000
New +$3.63M 0.01% 1160
2024
Q1
Sell
-26,900
Closed -$848K 2226
2023
Q4
$848K Hold
26,900
﹤0.01% 1444
2023
Q3
$755K Buy
+26,900
New +$924K ﹤0.01% 1416
2019
Q3
Sell
-1,250,000
Closed -$30M 1160
2019
Q2
$30M Buy
+1,250,000
New +$36.8M 0.16% 165
2017
Q2
Sell
-150,000
Closed -$5.78M 842
2017
Q1
$5.78M Buy
+150,000
New +$4.51M 0.03% 503

Other funds holding CC

Steven Cohen's CC Position: Q2 2026 in Review

Steven Cohen reduced its Chemours (CC) stake by 68% in Q2 2026, selling an estimated $9.48M and leaving 195,149 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Steven Cohen first reported a position in CC in Q3 2016 and has held it in 22 quarters since. The position peaked at $79.6M in Q1 2018. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Steven Cohen held 195,149 shares of Chemours worth $4M as of Q2 2026.
  • Steven Cohen sold 414,122 Chemours shares in Q2 2026, an estimated $9.48M.
  • Chemours made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1914 holding.
  • Steven Cohen first reported a position in Chemours in Q3 2016 and has held it in 22 quarters since.
  • Steven Cohen's Chemours position peaked at $79.6M in Q1 2018.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.